Addressing the Problem of Noncompliance With Inhalers By Design: the ‘patient-friendly‘ Approach

• Crompton G . A brief history of inhaled therapy over the past 50 years. Prim. Care Resp. J.15, 326–331 (2006).
   PubMedGoogle Scholar
• Melani AS , ZancettaD, BarbatoNet al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann. Allergy. Asthma Immunol. 93(5), 439–446 (2004).
   PubMed Web of Science ®Google Scholar
• Vincken W , DekhuijzenR, BarnesP. The ADMIT series – issues in inhalation therapy: 4) how to choose inhaler devices for the treatment of COPD. Prim. Care Respir. J.19(1), 10–20 (2010).
   PubMedGoogle Scholar
• Pedersen S , DubusJC, CromptonG. The ADMIT series – Issues in Inhalation Therapy: 5) Inhaler selection in children with asthma. Prim. Care Respir. J.19(3), 209–216 (2010).
   PubMedGoogle Scholar
• Lavorini F , LevyML, CorriganC, CromptonG. The ADMIT series – issues in inhalation therapy: 6) training tools for inhalation devices. Prim. Care Respir. J.19(4), 335–341 (2010).
   PubMedGoogle Scholar
• Melani AS , BonaviaM, CilentiVet al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir. Med. 105, 930–938 (2011).
   PubMed Web of Science ®Google Scholar
• Hardwell A , BarberV, HargadonT, McKnightE, HolmesJ, LevyML. Technique training does not improve the ability of most patients to use pressurized metered-dose inhalers (pMDIs). Prim. Care Respir. J.20(1), 92–96 (2011).
   PubMedGoogle Scholar
• Newman SP . Inhaler treatment options in COPD. Eur. Respir. Rev.14(96), 102–108 (2005).
   Google Scholar
• Everard ML . Nebulisers: Patient–Device Interactions. ERS Buyers Guide. European Respiratory Society. 148–157 (2009–2011).
   Google Scholar
• Dolovich MB , DhandR. Aerosol drug delivery: developments in device design and clinical use. Lancet.377, 1032–1045 (2011).
   PubMed Web of Science ®Google Scholar
• Laube BL , JanssensHM, DeJonghFHCet al. What the pulmonary specialist should know about the new inhalation therapies. Eur. Respir. J. 37, 1308–1331 (2011).
   PubMed Web of Science ®Google Scholar
• Cochrane MG , BalaMV, DownsKE, MauskopfJ, Ben-JosephRH. Inhaled corticosteroids for asthma therapy: patient compliance, device and technique. Chest117, 542–550 (2000).
   PubMed Web of Science ®Google Scholar
• Schulte M , OsseiranK, BetzRet al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J. Aerosol Med. Pulmon. Deliv. 21(4), 321–328 (2008).
   PubMed Web of Science ®Google Scholar
• Small M , VickersA, AndersonP, KayS. The patient-physician partnership in Asthma: real-world observations associated with clinical and patient-reported outcomes. Adv. Ther.27(9), 1–9 (2010).
   PubMedGoogle Scholar
• Mitchell JP . Improving the odds that patients and caregivers will use inhalers correctly: a manufacturer‘s response. Prim. Care Respir. J.20, 219–220 (2011).
   PubMedGoogle Scholar
• Mitchell JP , NagelMW. Valved holding chambers (VHCs) for use with pressurized metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. Prim. Care Respir. J.16(4), 207–214 (2007).
   PubMedGoogle Scholar
• Newman SP . Principles of metered-dose inhaler design. Respir. Care50(9), 1177–1190 (2005).
   PubMedGoogle Scholar
• Chapman K , FogartyCM, PeckittCet al. Delivery characteristics and patients‘ handling of two single-dose dry-powder inhalers used in COPD. Int. J. COPD 6, 353–363 (2011).
   Google Scholar
• Watt B , ClementsP, DevadasonS, ChaneyG. Funhaler spacer: improving adherence without compromising delivery. Arch. Dis. Child.88(7), 579–581 (2003).
   PubMed Web of Science ®Google Scholar
• Chapman K , VoshaarTH, VirchowJC. Inhaler choice in primary practice. Eur. Respir. Rev.14(96), 117–122 (2005).
   Google Scholar

Websites

• The Aerosol Drug Management Improvement Team website. www.admit-online.info/en
   Google Scholar
• US Federal Drug Administration. Guidance for industry: integration of dose-counting mechanisms into MDI drug products. March 2003. www.fda.gov/downloads/Drugs/ComplianceRegulatoryInformation/Guidances/ucm071731.pdf
   Google Scholar